| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |